Northbrook, IL 60062 -- (SBWire) -- 10/11/2023 --Respiratory Care Devices Market in terms of revenue was estimated to be worth $21.8 billion in 2023 and is poised to reach $31.8 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in this market can primarily be attributed to the Focus on improving patient outcomes and rising R&D investments resulting in technologically advanced devices. Respiratory therapists use several approaches to improve patients' respiratory health and overall outcome. For instance, incentive spirometry is an exercise to assist patients by taking long and deep breaths to gauge how well the lungs expand. Since it needs deep breaths, it will enhance the patient's ability to clear mucus from the lungs. Such activities are taught by therapists to patients, which propels the demand for respiratory care devices.
In the near future, the respiratory care devices industry is poised for remarkable growth and innovation. Fueled by advances in technology and an increasing awareness of respiratory health, this sector is set to witness a surge in demand for state-of-the-art devices and therapies. Miniaturization and portability will be key trends, making devices more user-friendly and accessible for patients. Moreover, the integration of artificial intelligence and telemedicine into respiratory care will revolutionize diagnosis and treatment, providing real-time monitoring and personalized interventions. With a growing aging population and the enduring threat of respiratory diseases, the industry's trajectory promises not only enhanced patient outcomes but also significant contributions to public health worldwide.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368
Browse in-depth TOC on "Respiratory Care Devices Market"
556 - Tables
61 - Figures
468 – Pages
Key Market Players:
The major players in the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Drägerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan).
The pulse oximeters segment holds the major share of the respiratory care monitoring devices market.
Based on product, the respiratory care monitoring devices market is segmented into pulse oximeters, capnographs and gas analyzers. The pulse oximeters segment accounted for the largest share of the respiratory care monitoring devices market in 2022. A large share of the pulse oximeters segment can be attributed to the development of innovative products, such as fingertip pulse oximeters & Bluetooth-enabled pulse oximeters, and their growing uptake.
The hospitals segment holds the major share of the respiratory care devices market.
Based on end user, the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), other end users. The hospitals segment holds the major share of the respiratory care devices market. Growing public-private partnerships to improve access to healthcare services—along with rapid developments in healthcare infrastructure and improving access to healthcare services—are expected to be the key factors driving the growth of the respiratory care devices market for hospitals in emerging economies in the coming years.
North America segment accounted for the largest share of the respiratory care devices market.
The global respiratory care devices market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the respiratory care devices market in 2022. The presence of advanced healthcare infrastructure and high healthcare expenditure in the North America are factors expected to drive the growth of the respiratory care devices market in the country. The high prevalence of asthma is expected to drive the demand for respiratory care devices in the US during the forecast period.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=368
Respiratory Care Devices Market Dynamics:
Drivers:
1. Rising prevalence of respiratory diseases
a. Rapid growth in global geriatric population
b. Urbanization and growing pollution levels
c. High prevalence of tobacco smoking
d. Changing lifestyles
2. Increasing incidence rate of preterm births
3. Growing outbreaks of infectious diseases affecting respiratory system
4. Growing population with sleep disorders
5. Improved patient outcomes using respiratory care devices
6. Rising r&d investments for technological advancement of medical devices
Restraints:
1. Unfavorable reimbursement scenario for respiratory care diagnostics
2. Availability of low-cost products from local manufacturers
3. High cost of cpap machines
Opportunities:
1. Growing demand for home care therapeutic devices
2. High respiratory care market growth opportunities in asia pacific and latin america
3. Improving poc diagnostics
4. Growing awareness about ill effects of untreated sleep apnea
Challenge:
1.Low awareness and lack of diagnosis of respiratory diseases
2.Harmful effects of certain respiratory care devices on neonates
3.Lack of patient compliance with cpap therapy
Industry trends:
1.Rising demand for enhanced compact and portable devices
2.Key focus of market players on geographical expansions
3.Growing demand for multimodal ventilation
4.Rising adoption of non-invasive ventilation
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=368
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Evaluating the Growth Potential of the Respiratory Care Devices Market: Insights, Strategic Forecasts, and Key Drivers for 2028
The global respiratory care devices market in terms of revenue was estimated to be worth $21.8 billion in 2023 and is poised to reach $31.8 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028.